Angela L Wong, MD
Family Practice · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Salinas Valley Health Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A70091 · Current
Licensed to practise in California · since 1999 · expires 2027-05-31 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$28,636
Medicare paid this office $28,636 for 85 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 40 | $9,588 | $155 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 46 | $7,233 | $157 |
| Return visit (30+ min) | 35 | $4,023 | $96 |
| Short return visit (20+ min) | 19 | $1,113 | $59 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 24 | $403 | $14 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
85 Original Medicare patients in 2024. Average age 77 · Under 65 0% · 85 and older 15% · Women 61% · Also on Medicaid 20% · Health risk score 0.90. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 64% · Coronary heart disease 31% · Chronic kidney disease 14% · Depression 14%.
The office billed $77,319, Medicare allowed $36,545 and paid $28,636; for 274 services of 28 kinds; $2,331 of it was for drugs given in the office and $26,306 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 85 | 274 | 77 | 0.90 | $77,319 | $28,636 |
| 2023 | 101 | 278 | 77 | 0.85 | $87,190 | $32,532 |
| 2022 | 117 | 294 | 76 | 0.76 | $83,152 | $33,032 |
| 2021 | 99 | 300 | 76 | 0.77 | $85,567 | $31,894 |
| 2020 | 109 | 249 | 77 | 0.87 | $64,200 | $20,709 |
| 2019 | 115 | 360 | 76 | 0.83 | $93,269 | $31,083 |
| 2018 | 105 | 336 | 75 | 0.85 | $90,869 | $29,319 |
| 2017 | 101 | 334 | 76 | 0.85 | $88,360 | $28,131 |
| 2016 | 117 | 418 | 75 | 0.86 | $115,170 | $39,228 |
| 2015 | 132 | 514 | 74 | 0.92 | $114,419 | $45,966 |
| 2014 | 125 | 321 | 73 | 0.81 | $76,120 | $25,596 |
| 2013 | 91 | 326 | 73 | 0.89 | $76,750 | $24,875 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 51 | $12,429 | $145 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $8,615 | $160 |
| Return visit (30+ min) | 38 | $4,655 | $91 |
| Short return visit (20+ min) | 19 | $1,246 | $66 |
2022: 6 services
| Long return visit (40+ min) | 59 | $12,890 | $150 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $7,918 | $158 |
| Return visit (30+ min) | 44 | $5,349 | $96 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 12 | $843 | $70 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 11 | $557 | $51 |
| Administration of influenza virus vaccine | 13 | $492 | $38 |
2021: 6 services
| Long return visit (40+ min) | 52 | $13,747 | $143 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 48 | $6,990 | $146 |
| Return visit (30+ min) | 45 | $4,808 | $91 |
| Short return visit (20+ min) | 12 | $790 | $56 |
| Influenza vaccine split virus, preservative free | 12 | $779 | $65 |
| Administration of influenza virus vaccine | 12 | $261 | $22 |
2020: 7 services
| Return visit (30+ min) | 70 | $6,627 | $75 |
| Long return visit (40+ min) | 29 | $4,227 | $114 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,949 | $141 |
| Short return visit (20+ min) | 21 | $1,261 | $57 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,127 | $94 |
| Influenza vaccine split virus, preservative free | 13 | $825 | $59 |
| Administration of influenza virus vaccine | 13 | $291 | $21 |
2019: 7 services
| Long return visit (40+ min) | 51 | $9,396 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 48 | $6,709 | $140 |
| Return visit (30+ min) | 65 | $6,385 | $73 |
| Short return visit (20+ min) | 34 | $2,097 | $55 |
| Influenza vaccine split virus, preservative free | 26 | $1,438 | $53 |
| Administration of influenza virus vaccine | 27 | $574 | $21 |
| Administration of pneumococcal vaccine | 11 | $226 | $21 |
2018: 6 services
| Long return visit (40+ min) | 47 | $10,253 | $110 |
| Return visit (30+ min) | 64 | $6,172 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $4,990 | $131 |
| Short return visit (20+ min) | 19 | $1,136 | $54 |
| Influenza vaccine split virus, preservative free | 18 | $773 | $43 |
| Administration of influenza virus vaccine | 23 | $618 | $26 |
2017: 8 services
| Long return visit (40+ min) | 47 | $9,600 | $110 |
| Return visit (30+ min) | 63 | $7,370 | $78 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $4,077 | $127 |
| Advance care planning, first 30 minutes | 11 | $946 | $86 |
| Short return visit (20+ min) | 20 | $815 | $41 |
| Administration of influenza virus vaccine | 21 | $701 | $32 |
| Influenza vaccine split virus, preservative free | 16 | $692 | $43 |
| Administration of pneumococcal vaccine | 11 | $334 | $30 |
2016: 8 services
| Long return visit (40+ min) | 63 | $16,996 | $119 |
| Return visit (30+ min) | 59 | $7,342 | $80 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $4,140 | $125 |
| Pneumococcal vaccine, 13-valent | 18 | $3,140 | $174 |
| Short return visit (20+ min) | 33 | $1,970 | $56 |
| Administration of influenza virus vaccine | 23 | $699 | $30 |
| Administration of pneumococcal vaccine | 21 | $638 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $236 | $18 |
2015: 10 services
| Return visit (30+ min) | 77 | $10,616 | $91 |
| Pneumococcal vaccine, 13-valent | 63 | $9,466 | $150 |
| Long return visit (40+ min) | 46 | $9,409 | $122 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,809 | $131 |
| Short return visit (20+ min) | 47 | $3,039 | $54 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $2,319 | $193 |
| Administration of pneumococcal vaccine | 64 | $1,944 | $30 |
| New patient visit (45+ min) | 12 | $1,344 | $112 |
| Administration of influenza virus vaccine | 25 | $789 | $32 |
| Influenza vaccine split virus, preservative free | 18 | $638 | $35 |
2014: 8 services
| Return visit (30+ min) | 79 | $8,131 | $77 |
| Long return visit (40+ min) | 34 | $6,769 | $121 |
| Short return visit (20+ min) | 36 | $2,394 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,132 | $125 |
| Pneumococcal vaccine, 23-valent | 13 | $828 | $64 |
| Administration of influenza virus vaccine | 19 | $577 | $30 |
| Administration of pneumococcal vaccine | 14 | $425 | $30 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 11 | $130 | $12 |
2013: 7 services
| Return visit (30+ min) | 57 | $8,417 | $85 |
| Long return visit (40+ min) | 39 | $8,179 | $117 |
| Short return visit (20+ min) | 27 | $1,951 | $56 |
| Pneumococcal vaccine, 23-valent | 11 | $706 | $64 |
| Administration of influenza virus vaccine | 14 | $428 | $31 |
| Administration of pneumococcal vaccine | 11 | $333 | $30 |
| Administration of vaccine | 15 | $294 | $20 |
Medicaid work
$1,412 in 2023
Medicaid paid $1,412 for 39 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 39 | $1,412 |
| 2023 | 39 | 1 | 14 | $1,412 |
Drugs they prescribed that Part D paid
$73,264
Pharmacies billed $73,264 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,295 generic and 116 brand-name prescriptions · $73,264 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $11,995 | $1,090 |
| Paxlovid | 12 | $2,859 | $238 |
| Rosuvastatin | 66 | $1,675 | $25 |
| Levothyroxine | 81 | $1,256 | $16 |
| Atorvastatin | 204 | $1,212 | $6 |
See all 28 drugs
| Eliquis | 11 | $11,995 | $1,090 |
| Paxlovid | 12 | $2,859 | $238 |
| Rosuvastatin | 66 | $1,675 | $25 |
| Levothyroxine | 81 | $1,256 | $16 |
| Atorvastatin | 204 | $1,212 | $6 |
| Losartan | 85 | $779 | $9 |
| Amlodipine Besylate | 115 | $716 | $6 |
| Metronidazole | 11 | $684 | $62 |
| Tamsulosin | 37 | $579 | $16 |
| Valsartan | 23 | $567 | $25 |
| Omeprazole | 32 | $555 | $17 |
| Zolpidem | 44 | $423 | $10 |
| Metformin | 28 | $395 | $14 |
| Sertraline | 43 | $395 | $9 |
| Alendronate | 29 | $381 | $13 |
| Azelastine | 12 | $354 | $30 |
| Fluticasone Propionate | 28 | $330 | $12 |
| Venlafaxine Hcl Er | 15 | $328 | $22 |
| Famotidine | 21 | $258 | $12 |
| Lisinopril | 45 | $258 | $6 |
| Metoprolol | 28 | $250 | $9 |
| Finasteride | 17 | $235 | $14 |
| Gabapentin | 19 | $233 | $12 |
| Metformin Hcl Er | 25 | $213 | $9 |
| Clonazepam | 11 | $123 | $11 |
| Potassium Chloride | 12 | $113 | $9 |
| Duloxetine | 15 | $103 | $7 |
| Hydrochlorothiazide | 15 | $29 | $2 |
Year by year
| 2024 | 1,411 | 150 | None | 8% | $73,264 |
| 2023 | 1,524 | 164 | 1% (20) | None | $95,300 |
| 2022 | 1,402 | 157 | 2% (25) | None | $90,786 |
| 2021 | 1,305 | 138 | 1% (17) | 9% | $90,725 |
| 2020 | 1,363 | 144 | 2% (21) | 11% | $81,541 |
| 2019 | 1,275 | 142 | 2% (29) | 12% | $74,169 |
| 2018 | 1,350 | 135 | 3% (44) | 16% | $91,554 |
| 2017 | 1,289 | 123 | 1% (16) | 16% | $80,514 |
| 2016 | 1,292 | 134 | 2% (23) | None | $65,031 |
| 2015 | 1,057 | 142 | 3% (36) | 18% | $57,701 |
| 2014 | 994 | 121 | 6% (57) | 16% | $47,348 |
| 2013 | 734 | 86 | 6% (43) | None | $39,835 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Atorvastatin | 223 | $3,551 | $16 |
| Tamsulosin | 44 | $1,778 | $40 |
| Wixela Inhub | 11 | $1,714 | $156 |
| Levothyroxine | 81 | $1,468 | $18 |
| Amlodipine Besylate | 97 | $1,367 | $14 |
| Losartan | 90 | $1,345 | $15 |
| Rosuvastatin | 49 | $1,282 | $26 |
| Alendronate | 55 | $1,193 | $22 |
| Metronidazole | 15 | $1,161 | $77 |
| Synthroid | 12 | $969 | $81 |
| Omeprazole | 34 | $762 | $22 |
| Azelastine | 20 | $609 | $30 |
| Finasteride | 22 | $588 | $27 |
| Lisinopril | 50 | $502 | $10 |
| Fluticasone Propionate | 31 | $430 | $14 |
| Famotidine | 30 | $417 | $14 |
| Metformin | 22 | $380 | $17 |
| Diclofenac | 16 | $368 | $23 |
| Zolpidem | 42 | $343 | $8 |
| Gabapentin | 21 | $316 | $15 |
| Metoprolol | 27 | $304 | $11 |
| Sertraline | 36 | $256 | $7 |
| Hydrocodone-Acetaminophen | 12 | $248 | $21 |
| Escitalopram | 12 | $168 | $14 |
| Metformin Hcl Er | 18 | $143 | $8 |
| Clonazepam | 11 | $125 | $11 |
| Triamcinolone Acetonide | 15 | $97 | $6 |
| Hydrochlorothiazide | 15 | $45 | $3 |
2022: 25 drugs
| Qvar Redihaler | 13 | $3,453 | $266 |
| Atorvastatin | 200 | $2,037 | $10 |
| Rosuvastatin | 37 | $1,604 | $43 |
| Levothyroxine | 73 | $1,382 | $19 |
| Synthroid | 13 | $1,165 | $90 |
| Azelastine | 24 | $979 | $41 |
| Gabapentin | 42 | $934 | $22 |
| Amlodipine Besylate | 107 | $887 | $8 |
| Alendronate | 69 | $713 | $10 |
| Tamsulosin | 35 | $695 | $20 |
| Losartan | 77 | $661 | $9 |
| Hydrocodone-Acetaminophen | 17 | $467 | $27 |
| Metoprolol | 31 | $459 | $15 |
| Valsartan | 11 | $440 | $40 |
| Zolpidem | 36 | $389 | $11 |
| Omeprazole | 32 | $356 | $11 |
| Valacyclovir | 11 | $342 | $31 |
| Metformin | 22 | $316 | $14 |
| Finasteride | 19 | $314 | $17 |
| Famotidine | 18 | $264 | $15 |
| Lisinopril | 42 | $241 | $6 |
| Sertraline | 25 | $128 | $5 |
| Losartan-Hydrochlorothiazide | 11 | $109 | $10 |
| Hydrochlorothiazide | 15 | $64 | $4 |
| Metformin Hcl Er | 12 | $56 | $5 |
2021: 25 drugs
| Atorvastatin | 215 | $3,459 | $16 |
| Synthroid | 13 | $1,656 | $127 |
| Levothyroxine | 75 | $1,565 | $21 |
| Amlodipine Besylate | 105 | $1,349 | $13 |
| Gabapentin | 25 | $1,083 | $43 |
| Tamsulosin | 44 | $831 | $19 |
| Rosuvastatin | 27 | $695 | $26 |
| Omeprazole | 50 | $654 | $13 |
| Alendronate | 62 | $623 | $10 |
| Finasteride | 21 | $559 | $27 |
| Metoprolol | 28 | $488 | $17 |
| Losartan | 37 | $463 | $13 |
| Lisinopril | 52 | $450 | $9 |
| Hydrocodone-Acetaminophen | 13 | $426 | $33 |
| Azelastine | 14 | $379 | $27 |
| Famotidine | 15 | $294 | $20 |
| Metformin | 23 | $279 | $12 |
| Fluticasone Propionate | 13 | $244 | $19 |
| Potassium Chloride | 11 | $230 | $21 |
| Zolpidem | 21 | $169 | $8 |
| Hydrochlorothiazide | 21 | $145 | $7 |
| Simvastatin | 20 | $133 | $7 |
| Sertraline | 17 | $100 | $6 |
| Triamcinolone Acetonide | 18 | $81 | $4 |
| Furosemide | 11 | $70 | $6 |
2020: 27 drugs
| Januvia | 11 | $9,137 | $831 |
| Flovent Hfa | 11 | $3,279 | $298 |
| Atorvastatin | 176 | $2,612 | $15 |
| Levothyroxine | 60 | $1,677 | $28 |
| Amlodipine Besylate | 95 | $978 | $10 |
| Tamsulosin | 40 | $833 | $21 |
| Alendronate | 103 | $795 | $8 |
| Ibandronate | 11 | $771 | $70 |
| Losartan | 42 | $746 | $18 |
| Hydrocodone-Acetaminophen | 15 | $635 | $42 |
| Metoprolol | 32 | $570 | $18 |
| Cyclobenzaprine | 16 | $545 | $34 |
| Gabapentin | 25 | $449 | $18 |
| Rosuvastatin | 28 | $420 | $15 |
| Omeprazole | 48 | $402 | $8 |
| Famotidine | 16 | $330 | $21 |
| Metformin | 25 | $284 | $11 |
| Lisinopril | 34 | $284 | $8 |
| Trazodone | 29 | $276 | $10 |
| Potassium Chloride | 12 | $274 | $23 |
| Hydrochlorothiazide | 27 | $200 | $7 |
| Finasteride | 15 | $188 | $13 |
| Simvastatin | 30 | $165 | $6 |
| Sertraline | 18 | $130 | $7 |
| Triamcinolone Acetonide | 11 | $100 | $9 |
| Metformin Hcl Er | 11 | $60 | $5 |
| Zolpidem | 13 | $44 | $3 |
2019: 31 drugs
| Linzess | 11 | $4,533 | $412 |
| Qvar Redihaler | 12 | $3,734 | $311 |
| Atorvastatin | 165 | $3,021 | $18 |
| Levothyroxine | 63 | $1,760 | $28 |
| Tamsulosin | 42 | $831 | $20 |
| Amlodipine Besylate | 74 | $797 | $11 |
| Metoprolol | 33 | $784 | $24 |
| Ranitidine | 21 | $702 | $33 |
| Alendronate | 84 | $623 | $7 |
| Hydrocodone-Acetaminophen | 16 | $534 | $33 |
| Valsartan | 11 | $481 | $44 |
| Cyclobenzaprine | 19 | $460 | $24 |
| Famotidine | 17 | $416 | $24 |
| Valacyclovir | 11 | $384 | $35 |
| Finasteride | 14 | $383 | $27 |
| Losartan | 27 | $366 | $14 |
| Warfarin | 17 | $366 | $22 |
| Lisinopril | 52 | $336 | $6 |
| Rosuvastatin | 20 | $299 | $15 |
| Gabapentin | 16 | $274 | $17 |
| Omeprazole | 44 | $257 | $6 |
| Clopidogrel | 11 | $243 | $22 |
| Hydrochlorothiazide | 42 | $237 | $6 |
| Zolpidem | 16 | $193 | $12 |
| Sertraline | 18 | $191 | $11 |
| Metformin | 13 | $165 | $13 |
| Simvastatin | 32 | $159 | $5 |
| Atenolol | 11 | $126 | $11 |
| Triamcinolone Acetonide | 12 | $98 | $8 |
| Metformin Hcl Er | 11 | $92 | $8 |
| Trazodone | 12 | $90 | $8 |
2018: 31 drugs
| Januvia | 28 | $19,032 | $680 |
| Uloric | 11 | $3,428 | $312 |
| Atorvastatin | 159 | $2,794 | $18 |
| Voltaren | 20 | $2,567 | $128 |
| Levothyroxine | 61 | $1,961 | $32 |
| Ranitidine | 41 | $1,358 | $33 |
| Tamsulosin | 40 | $1,048 | $26 |
| Oxybutynin Chloride Er | 11 | $880 | $80 |
| Gabapentin | 35 | $789 | $23 |
| Metoprolol | 22 | $734 | $33 |
| Valsartan | 18 | $572 | $32 |
| Amlodipine Besylate | 74 | $503 | $7 |
| Losartan | 40 | $477 | $12 |
| Sertraline | 35 | $427 | $12 |
| Lisinopril | 57 | $400 | $7 |
| Rosuvastatin | 18 | $387 | $21 |
| Finasteride | 14 | $316 | $23 |
| Omeprazole | 48 | $314 | $7 |
| Metformin | 33 | $307 | $9 |
| Hydrocodone-Acetaminophen | 19 | $300 | $16 |
| Hydrochlorothiazide | 50 | $277 | $6 |
| Aripiprazole | 11 | $217 | $20 |
| Alendronate | 31 | $216 | $7 |
| Triamcinolone Acetonide | 12 | $196 | $16 |
| Atenolol | 16 | $191 | $12 |
| Fluticasone Propionate | 13 | $190 | $15 |
| Donepezil | 13 | $152 | $12 |
| Zolpidem | 12 | $148 | $12 |
| Cyclobenzaprine | 12 | $136 | $11 |
| Simvastatin | 20 | $129 | $6 |
| Furosemide | 12 | $86 | $7 |
2017: 32 drugs
| Januvia | 25 | $16,535 | $661 |
| Eliquis | 12 | $4,704 | $392 |
| Namenda Xr | 12 | $4,567 | $381 |
| Uloric | 11 | $3,216 | $292 |
| Levothyroxine | 67 | $2,162 | $32 |
| Atorvastatin | 131 | $2,131 | $16 |
| Econazole Nitrate | 15 | $2,082 | $139 |
| Tamsulosin | 42 | $1,161 | $28 |
| Synthroid | 12 | $1,108 | $92 |
| Metoprolol | 30 | $1,083 | $36 |
| Ranitidine | 31 | $850 | $27 |
| Omeprazole | 62 | $632 | $10 |
| Acarbose | 12 | $531 | $44 |
| Amlodipine Besylate | 69 | $520 | $8 |
| Sertraline | 35 | $506 | $14 |
| Clopidogrel | 20 | $387 | $19 |
| Metformin | 45 | $380 | $8 |
| Aripiprazole | 11 | $374 | $34 |
| Gabapentin | 13 | $365 | $28 |
| Losartan | 44 | $345 | $8 |
| Finasteride | 11 | $267 | $24 |
| Fluticasone Propionate | 23 | $249 | $11 |
| Simvastatin | 35 | $238 | $7 |
| Warfarin | 14 | $238 | $17 |
| Alendronate | 36 | $229 | $6 |
| Cyclobenzaprine | 20 | $211 | $11 |
| Lisinopril | 35 | $189 | $5 |
| Hydrochlorothiazide | 33 | $163 | $5 |
| Triamcinolone Acetonide | 14 | $148 | $11 |
| Zolpidem | 14 | $111 | $8 |
| Donepezil | 18 | $109 | $6 |
| Atenolol | 13 | $80 | $6 |
2016: 31 drugs
| Januvia | 15 | $9,905 | $660 |
| Atorvastatin | 111 | $2,705 | $24 |
| Levothyroxine | 82 | $2,137 | $26 |
| Metoprolol | 32 | $1,666 | $52 |
| Synthroid | 13 | $1,197 | $92 |
| Tamsulosin | 31 | $879 | $28 |
| Ranitidine | 26 | $701 | $27 |
| Omeprazole | 55 | $661 | $12 |
| Hydrocodone-Acetaminophen | 17 | $621 | $37 |
| Simvastatin | 49 | $577 | $12 |
| Losartan | 33 | $556 | $17 |
| Amlodipine Besylate | 59 | $554 | $9 |
| Metformin | 39 | $514 | $13 |
| Clopidogrel | 20 | $488 | $24 |
| Fluticasone Propionate | 23 | $445 | $19 |
| Sertraline | 49 | $430 | $9 |
| Alendronate | 52 | $427 | $8 |
| Zolpidem | 12 | $391 | $33 |
| Chlorthalidone | 12 | $330 | $28 |
| Finasteride | 12 | $294 | $24 |
| Gabapentin | 18 | $290 | $16 |
| Lisinopril | 32 | $231 | $7 |
| Isosorbide Mononitrate Er | 11 | $229 | $21 |
| Hydrochlorothiazide | 20 | $160 | $8 |
| Topiramate | 12 | $156 | $13 |
| Cyclobenzaprine | 11 | $142 | $13 |
| Glipizide | 14 | $126 | $9 |
| Triamcinolone Acetonide | 14 | $122 | $9 |
| Baclofen | 17 | $104 | $6 |
| Carvedilol | 13 | $77 | $6 |
| Lorazepam | 13 | $69 | $5 |
2015: 26 drugs
| Januvia | 16 | $11,093 | $693 |
| Premarin | 11 | $2,748 | $250 |
| Levothyroxine | 74 | $2,022 | $27 |
| Atorvastatin | 75 | $1,687 | $22 |
| Metoprolol | 25 | $1,379 | $55 |
| Tamsulosin | 20 | $1,226 | $61 |
| Synthroid | 18 | $1,195 | $66 |
| Proair Hfa | 13 | $773 | $59 |
| Omeprazole | 37 | $613 | $17 |
| Hydrocodone-Acetaminophen | 26 | $575 | $22 |
| Simvastatin | 45 | $498 | $11 |
| Cyclobenzaprine | 17 | $479 | $28 |
| Gabapentin | 33 | $464 | $14 |
| Alendronate | 36 | $458 | $13 |
| Amlodipine Besylate | 43 | $356 | $8 |
| Clopidogrel | 24 | $354 | $15 |
| Losartan | 25 | $338 | $14 |
| Fluticasone Propionate | 16 | $329 | $21 |
| Finasteride | 13 | $271 | $21 |
| Metformin | 26 | $227 | $9 |
| Sertraline | 26 | $214 | $8 |
| Lisinopril | 16 | $137 | $9 |
| Hydrochlorothiazide | 23 | $118 | $5 |
| Glipizide | 15 | $97 | $6 |
| Promethazine | 15 | $57 | $4 |
| Trazodone | 13 | $43 | $3 |
2014: 26 drugs
| Coreg Cr | 11 | $4,352 | $396 |
| Atorvastatin | 59 | $1,509 | $26 |
| Levothyroxine | 58 | $1,211 | $21 |
| Oxybutynin Chloride Er | 14 | $1,127 | $80 |
| Metoprolol | 22 | $888 | $40 |
| Hydrocodone-Acetaminophen | 40 | $774 | $19 |
| Synthroid | 11 | $732 | $67 |
| Carisoprodol | 12 | $484 | $40 |
| Tamsulosin | 21 | $465 | $22 |
| Alendronate | 42 | $457 | $11 |
| Fluticasone Propionate | 24 | $445 | $19 |
| Losartan | 26 | $434 | $17 |
| Amlodipine Besylate | 31 | $370 | $12 |
| Pravastatin | 12 | $340 | $28 |
| Simvastatin | 26 | $335 | $13 |
| Omeprazole | 21 | $274 | $13 |
| Sertraline | 29 | $264 | $9 |
| Metformin | 22 | $256 | $12 |
| Clopidogrel | 15 | $236 | $16 |
| Lisinopril | 26 | $219 | $8 |
| Lorazepam | 22 | $184 | $8 |
| Zolpidem | 19 | $181 | $10 |
| Glipizide | 22 | $160 | $7 |
| Citalopram Hbr | 23 | $151 | $7 |
| Hydrochlorothiazide | 28 | $121 | $4 |
| Clonazepam | 13 | $94 | $7 |
2013: 19 drugs
| Clopidogrel | 16 | $2,886 | $180 |
| Atorvastatin | 47 | $2,033 | $43 |
| Losartan | 36 | $596 | $17 |
| Omeprazole | 16 | $514 | $32 |
| Lisinopril | 32 | $493 | $15 |
| Amlodipine Besylate | 21 | $388 | $18 |
| Metoprolol | 13 | $374 | $29 |
| Metformin | 26 | $347 | $13 |
| Hydrocodone-Acetaminophen | 39 | $339 | $9 |
| Valacyclovir | 14 | $286 | $20 |
| Tamsulosin | 11 | $280 | $25 |
| Alendronate | 22 | $239 | $11 |
| Levothyroxine | 15 | $226 | $15 |
| Lorazepam | 17 | $191 | $11 |
| Citalopram Hbr | 21 | $142 | $7 |
| Benazepril | 11 | $141 | $13 |
| Zolpidem | 18 | $103 | $6 |
| Sertraline | 17 | $102 | $6 |
| Hydrochlorothiazide | 19 | $65 | $3 |
Money from drug and device companies
$24 in 2025
| 2025 | 1 | 1 | None | $24 |
| 2023 | 1 | 1 | None | $105 |
| 2022 | 1 | 1 | None | $19 |
| 2020 | 1 | 1 | None | $15 |
| 2019 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $24 | 1 payment
|
See the published payment
| Dexcom | Meals · 2025-09-24 | Dexcom G6 Transmitter | $24 |
See earlier years (2023, 2022, 2020, 2019)
2023: $105
| AstraZeneca Pharmaceuticals LP | Saphnelo | $105 | 1 payment
|
2022: $19
| Kowa Pharmaceuticals America | Livalo | $19 | 1 payment
|
2020: $15
| Sunovion Pharmaceuticals | Lonhala Magnair | $15 | 1 payment
|
2019: $24
| Shire North American Group | Natpara (Parathyroid Hormone) | $24 | 1 payment
|
Professional record
- NPI
- 1942391602
- Licence
- CA A70091California A70091: Current · expires 2027-05-31
- Trained
- University of Michigan Medical School, 1998
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-09-27
- NPI last updated
- 2020-03-04
- NPI record certified
- 2020-03-04
This is when the NPI record was last certified, not a medical board exam.